Publications

1. Rebelo M, De novo hACE2 decoy NL-CVX1 protects mice from severe disease following SARS-CoV-2. J Infect Dis. 2023, doi: 10.1093/infdis/jiad135.

2. Mikutis S*, Rebelo M*, Yankova E, et al. Proximity-Induced Nucleic Acid Degrader (PINAD) Approach to Targeted RNA Degradation Using Small Molecules. ACS Cent Sci. 2023 https://doi.org/10.1021/acscentsci.3c00015 (*shared co-first authorship)

3. Tang C*, Coelho AR*, Rebelo M*, et al. A Selective SARS-CoV-2 Host-Directed Antiviral Targeting Stress Response to Reactive Oxygen Species. ACS Cent Sci. 2023;9(1):109-121. (*shared co-first authorship)

4. Rebelo M, Pawliw R, Gower J, Webb L, Mitchell H, Pava Z, Watts RE, Davenport MP, McCarthy JS, Khoury DS. Parasite viability is a superior measure of anti-malarial drug activity in humans. The Journal of Infectious Diseases 2020. 

5. Orbán A*, Rebelo M*, Molnár P, I S Albuquerque, Butykai A, Kézsmárki I. Efficient monitoring of the blood-stage infection in a malaria rodent model by the rotating-crystal magneto-optical method. Scientific Reports 2016; 6:23218. (*shared co-first authorship) 

6.  Rebelo M, Hanscheid T. Flow cytometry for antimalarial drug testing – more than meets the eye. J Clin Microbiol 2016; 54(3):817. 

7. Rebelo M, Grenho R, Orban A, Hanscheid T. Hemozoin-based non-invasive diagnosis of malaria: already there? Emerg Infect Dis 2016 Feb;22(2):343-4.

8. Rebelo M, Tempera C, Bispo C, Andrade C, Gardner R, Shapiro HM, Hänscheid T. Light depolarization measurements in malaria: A new job for an old friend. Cytometry A 2015;87(5):437-45

9. Rebelo M, Tempera C, Fernandes JF, Grobusch MP, Hänscheid T.  Assessing anti-malarial drug effects ex vivo using the haemozoin detection assay. Malaria Jorunal 2015; 14:140. 

10. Rebelo M, Sousa C, Shapiro HM, Mota MM, Grobusch MP, Hanscheid T. A novel flow cytometric hemozoin detection assay for real-time sensitivity testing of Plasmodium falciparum. PlosOne 2013; 8(4):e61606. 

11. Rebelo M, Shapiro HM, Amaral T, Melo-Cristino J, Hänscheid T. Haemozoin detection in infected erythrocytes for P. falciparum malaria diagnosis – prospects and limitations. Acta Tropica 2012;123(1):58-61. 

12.  Frita R*, Rebelo M*, Pamplona A, Vigario AM, Mota MM, Grobusch MP, Hänscheid T. Simple flow cytometric detection of haemozoin containing leukocytes and erythrocytes for research on diagnosis, immunology and drug sensitivity testing. Malaria Journal 2011; 10:74. (* shared co-first authorship) 

13. Radohery GFR, Gower J, Barber BE, Kansagra K, Möhrle JJ, Davenport MP, McCarthy JS, Khoury DS, Rebelo M. Effect of novel antimalarial ZY-19489 on Plasmodium falciparum viability in a volunteer infection study. Lancet Infect Dis. 2022; 22(6):760-761.

14. Hanscheid T, Mahomed SM, Rebelo M, Henriques SO, Grobusch MP. Inaccurate communication in health sciences: The case of 'partial artemisinin resistance' for the treatment of malaria. New Microbes New Infect. 2024;62:101544. doi: 10.1016/j.nmni.2024.101544. 

15. Schneider MP, Looker O, Rebelo M, Khoury DS, Dixon MWA, Oeuvray C, Crabb BS, McCarthy J, Gilson PR. The delayed bloodstream clearance of Plasmodium falciparum parasites after M5717 treatment is attributable to the inability to modify their red blood cell hosts. bioRxiv 2023.04.24.538013; doi: https://doi.org/10.1101/2023.04.24.538013 (Contribution: human experimental data, sample collection, data analysis, results interpretation).  

16.  Radohery G, Walz A, Gumpp C, Cherkaoui-Rbati M, Gobeau N, Gower J, Davenport MP, Rottmann M, McCarthy JS, Möhrle J, Rebelo M, Demarta-Gatsi C, Khoury DS. Parasite viability as a measure of in vivo drug activity in preclinical and early clinical antimalarial drug assessment. Antimicrobial Agents and Chemotherapy, 2022:e0011422. (Contribution: experimental design, sample collection data analysis, results interpretation and manuscript writing).  

17.  Woolley SD, Fernandez M, Rebelo M, Llewellyn S, Marquart L, Amante F, Jennings H, Rebecca Webster R, Trenholme K, Chalon S, Moehrle J, McCarthy J, Barber B. Development and evaluation of new P. falciparum 3D7 blood stage malaria cell bank for use in malaria volunteer infection studies. Malaria Journal, 2021. (Contribution: design of the study and data analysis).

18.  Pava Z, Mok S, Collins K, Rebelo M, Watts RE, Robinson G, Wang C, Mitchel H, Lynch S, Webb L, McEwan S, Dixon M, Marquart L, Barber BE, Moehrle JJ, Fidock DA, McCarthy JS. Plasmodium falciparum artemisinin-resistant K13 mutations confer a sexual-stage transmission advantage that can be overcome with atovaquone-proguanil. medRxiv 2020. (Contribution: experimental design and results interpretation).  

19.  Odedra A, Mudie K, Kennedy G, Watts RE, Rossignol E, Mitchell H, Gower J, Rebelo M, Pava Z, Pawliw R, Woolley S, Lalloo D, Robinson G, Lynch S, Collins K, Amante F, McCarthy JS. Safety and feasibility of apheresis to harvest and concentrate parasites from subjects with induced blood stage Plasmodium vivax infection. Malaria Journal, 2020. (Contribution: design of the study, flow cytometry measurements and data analysis)

20.  Watts RE, Odedra A, Marquart L, Webb L, Abd-Rahman AN, Cascales L, Chalon S, Rebelo M, Pava Z, Collins, Pasay C, Chen Q, Peatey CL, Möhrle JJ, McCarthy JS. Safety and parasite clearance of artemisinin-resistant Plasmodium falciparum infection: A pilot and a randomised volunteer infection study in Australia. Plos Medicine, 2020. (Contribution: design of the study, sample collection and processing, data analysis, results interpretation and manuscript writing)

21.  Khoury DS, Cromer D, Grigg MJ, Zaloumis SG, Rebelo M, Cao P, McCaw JM, Simpson JA, Flegg JA, Wilson D, Anstey NM, McCarthy JS, Haque A, Davenport MP. Malaria parasite clearance: What are we really measuring? Trends in Parasitology 2020; 36(5):413-426. (Contribution: development and discussion of the ideas presented in this review and manuscript writing). 

22.  Hänscheid T, Rebelo M, Grobusch MP. Point-of-care tests: where is the point? Lancet Infect Dis 2014;14(10):922. (Contribution: development of the ideas presented in this communication and manuscript writing).

23.  Orbán A, Butykai A, Molnár A, Pröhle Z, Fülöp G, Zelles T, Forsyth W, Hill D, Müller I, Schofield L, Rebelo M, Hänscheid T, Karl S, Kézsmárki I. Evaluation of a novel magneto-optical method for the detection of malaria parasites. PLoS One 2014; 9(5):e96981. (Contribution: performed P. falciparum culturing and data analysis).

24.  Shapiro HM, Apte SH, Chojnowski GM, Hanscheid T, Rebelo M, Grimberg BT. Cytometry in malaria – a practical replacement for microscopy? Curr Protoc Cytom 2013; Chapter 11:Unit 11.20. (Contribution: development and discussion of the ideas presented in this article and manuscript writing).

25.  Hanson KK, Ressurreição AS, Buchholz K, Prudêncio M, Herman J, Rebelo M, Beatty WL, Wirth D, Hänscheid T, Moreira R, Marti M, and Mota MM. Torins are potent antimalarials that block replenishment of Plasmodium liver stage parasitophorous vacuole membrane proteins. PNAS 2013; 110(30):E2838-47. (Contribution: performed in vitro drug assays against P. falciparum and data analaysis).